FrancophonIA/ELRC3.0 huggingface dataset:
English: 1 sterile, single use, foil overwrapped, polypropylene bag containing VFEND solvent for solution for infusion in one compartment (50 ml).
Hungarian: 1 borża sterili tal-polypropylene, foil overwrapped, li tintuża darba biss, li jkun fiha VFEND solvent għal soluzzjoni għall-infużjoni f'kompartiment wieħed (50 ml).
English: Blood and lymphatic system disorders agranulocytosis pancytopenia, thrombocytopenia leukopenia, anaemia bone marrow failure, lymphadenopathy, eosinophilia disseminated intravascular coagulation
Hungarian: Disturbi taddemm u tassistema limfatika agranuloċitożi panċitopenja, tromboċitopenja lewkopenja, anemija insuffiċjenza talmudullun, limfadenopatija, esinofilja koagulazzjoni intravaskulari mifruxa
English: 2a Snap open Blue port. Bend the outer tube by 90° each way to ensure it is fully broken.
Hungarian: 90° kull naħa biex tkun ċert li tqaċċat kompletament.
English: The predicted total exposure in children following an oral maintenance dose of 9 mg/kg (maximum of 350 mg) twice daily was comparable to that in adults following 200 mg oral twice daily.
Hungarian: L-esponiment totali mbassar fit-tfal wara doża ta' manteniment orali ta' 9 mg/kg (massimu ta' 350 mg) darbtejn kuljum kien kumparabbli ma' dak fl-adulti wara doża orali ta' 200 mg darbtejn kuljum.
English: Voriconazole also significantly increases efavirenz plasma concentrations (see section 4.5, for lower doses see section 4.4).
Hungarian: Voriconazole ukoll jżid b'mod sinifikanti il-konċentrazzjonijiet ta' efavirenz fil-plasma (ara sezzjoni 4.5, għal dożi aktar baxxi ara sezzjoni 4.4).
English: VFEND 200 mg film-coated tablets White to off-white, capsule-shaped tablet, debossed “Pfizer” on one side and “VOR200”on the reverse.
Hungarian: Pillola ta' kulur abjad għal offwajt, b'forma ta' kapsula, bi “Pfizer” imnaqqax fuq naħa u “VOR200” fuq in-naħa l-oħra.
English: Hepatic impairment After an oral single-dose (200 mg), AUC was 233% higher in subjects with mild to moderate hepatic cirrhosis (Child-Pugh A and B) compared with subjects with normal hepatic function.
Hungarian: Wara doża waħda orali (200 mg), AUC kien 233% ogħla f'suġġetti b'ċirrożi tal-fwied ħafifa għal moderata (Child-Pugh A u B) meta mqabbel ma' pazjenti b'funzjoni normali tal-fwied.
English: In vitro studies showed that voriconazole is metabolised by the hepatic cytochrome P450 isoenzymes CYP2C19, CYP2C9 and CYP3A4.
Hungarian: Studji in vitro wrew li voriconazole huwa metabolizzat mill-isoenzimi taċ-ċitokromu tal-fwied P450, CYP2C19, CYP2C9 U CYP3A4.
English: In patients with moderate to severe renal dysfunction (serum creatinine levels > 2.5 mg/dl), accumulation of the intravenous vehicle, SBECD, occurs (see sections 4.2 and 4.4).
Hungarian: F'pazjenti b'disfunzjoni tal-kliewi moderata għal severa (livelli tal-kreatinina fis-serum > 2.5 mg /dl), isseħħ l-akkumulazzjoni tal-prodott mogħti ġol-vini, SBECD (ara sezzjonijiet 4.2 u 4.4).
English: Immune system disorders hypersensitivity anaphylactoid reaction
Hungarian: Disturbi fissistema immuni sensittività eċċessiva reazzjoni anafilaktojdi
English: Blister pack for 50 mg film-coated tablets - Pack of 2, 10, 14, 20, 28, 30, 50, 56, 100
Hungarian: Pakkett folji għal pilloli ta' 5 mg miksijin b'rita - Pakkett ta' 2, 10, 14, 20, 28, 30, 50, 56, 100
English: VFEND 200 mg powder for solution for infusion and VFEND 200 mg powder and solvent for solution for infusion:
Hungarian: VFEND 200 mg trab għal soluzzjoni għall-infużjoni u VFEND 200 mg trab u solvent għal soluzzjoni għall-infużjoni:
English: Rifabutin Cmax  195% Rifabutin AUC  331% Compared to voriconazole 200 mg BID,
Hungarian: Rifabutin Cmax  195% Rifabutin AUC  331% Ikkumparat ma' 200 mg BID, Voriconazole Cmax  104% Voriconazole AUC  87%
English: Solvent for solution for infusion: Sodium chloride 0.9% in Water for Injections
Hungarian: Solvent għal soluzzjoni għall-infużjoni: Sodium chloride 0.9% f'Ilma għall-Injezzjonijiet
English: The overall incidence of transaminase increases >3 xULN (not necessarily comprising an adverse event) in the voriconazole clinical programme was 18.0% (319/1,768) in adults and 25.8% (73/283) in paediatric subjects who received voriconazole for pooled therapeutic and prophylaxis use.
Hungarian: L-inċidenza globali ta' żidiet fit-transaminase >3 x ULN (mhux bilfors jinkludu episodju avvers) filprogramm kliniku b'voriconazole kienet 18.0% (319/1,768) fl-adulti u 25.8% (73/283) fil-pazjenti pedjatriċi li rċevew voriconazole għal użu terapewtiku u ta' profilassi miġbur.
English: Success at day 180*
Hungarian: Suċċess f'jum 180*
English: Includes nuchal rigidity and tetany.
Hungarian: Tinkludi riġidità nuċali u tetanija.
English: In vitro data showed a slight increase of resistance of C. glabrata to voriconazole.
Hungarian: Data in vitro wriet żieda żgħira firreżistenzata' C. glabrata għal voriconazole.
English: Fluconazole (CYP2C9, CYP2C19 and CYP3A4 inhibitor) Coadministration of oral voriconazole and oral fluconazole resulted in a significant increase in Cmax and AUCτ of voriconazole in healthy subjects.
Hungarian: Fluconazole (inibitur ta' CYP2C9, CYP2C19 u CYP3A4) Amministrazzjoni ta' voriconazole li jittieħed mill-ħalq flimkien ma' fluconazole li jittieħed mill-ħalq rriżulta f'żieda sinifikanti f'Cmax u AUCτ ta' voriconazole f'suġġetti b'saħħithom.
English: Renal adverse reactions
Hungarian: Reazzjonijiet avversi tal-vista
English: EU/1/02/212/013 2 film-coated tablets EU/1/02/212/014 10 film-coated tablets EU/1/02/212/015 14 film-coated tablets EU/1/02/212/016 20 film-coated tablets EU/1/02/212/017 28 film-coated tablets EU/1/02/212/018 30 film-coated tablets EU/1/02/212/019 50 film-coated tablets EU/1/02/212/020 56 film-coated tablets EU/1/02/212/021 100 film-coated tablets EU/1/02/212/037 2 film-coated tablets EU/1/02/212/038 10 film-coated tablets EU/1/02/212/039 14 film-coated tablets EU/1/02/212/040 20 film-coated tablets EU/1/02/212/041 28 film-coated tablets EU/1/02/212/042 30 film-coated tablets EU/1/02/212/043 50 film-coated tablets EU/1/02/212/044 56 film-coated tablets EU/1/02/212/045 100 film-coated tablets
Hungarian: EU/1/02/212/037 2 pilloli miksijin b'rita EU/1/02/212/038 10 pilloli miksijin b'rita EU/1/02/212/039 14-il pillola miksijin b'rita EU/1/02/212/040 20 pillola miksijin b'rita EU/1/02/212/041 28 pillola miksijin b'rita EU/1/02/212/042 30 pillola miksijin b'rita EU/1/02/212/043 50 pillola miksijin b'rita EU/1/02/212/044 56 pillola miksijin b'rita EU/1/02/212/045 100 pillola miksijin b'rita
English: Blister pack for 200 mg film-coated tablets - Pack of 2, 10, 14, 20, 28, 30, 50, 56, 100
Hungarian: Pakkett folji għal pilloli ta' 200 mg miksijin b'rita - Pakkett ta' 2, 10, 14, 20, 28, 30, 50, 56, 100
English: As you will be given this medicine under close medical supervision, it is unlikely that a dose would be missed.
Hungarian: Billi inti se tingħata din il-mediċina taħt sorveljanza medika mill-qrib, mhux probabbli li tfalli doża.
English: Dose reduction of alfentanil, fentanyl and other short-acting opiates similar in structure to alfentanil and metabolised by CYP3A4 (e.g., sufentanil) should be considered.
Hungarian: Tnaqqis fid-doża ta' alfentanil, fentanyl u opiates oħra li jaħdmu fuq qasir żmien bi struttura simili għal alfentanil u metabolizzati minn CYP3A4 (e.ż., sufentanil) għandhom ikunu kkunsidrati.
English: • Sirolimus (used in transplant patients)
Hungarian: • Sirolimus (użat f'pazjenti tat-trapjanti)
English: Compared to efavirenz 600 mg QD, Efavirenz Cmax ↔ Efavirenz AUC  17%
Hungarian: Efavirenz Cmax ↔ Efavirenz AUC  17%
English: In clinical trials, visual impairments (including blurred vision, photophobia, chloropsia, chromatopsia, colour blindness, cyanopsia, eye disorder, halo vision, night blindness, oscillopsia, photopsia, scintillating scotoma, visual acuity reduced, visual brightness, visual field defect, vitreous floaters, and xanthopsia) with voriconazole were very common.
Hungarian: Fi studji kliniċi, indebolimenti viżwali (inkluż vista mċajpra, fotofobija, kloropsija, kromatopsija, ma tarax il-kulur tajjeb, ċjanopsija, disturbi fl-għajnejn, tara raġġieri, ma tarax billejl, oxxillopsija, fotopsija, skotoma xintillanti, preċiżjoni viżiva mnaqqsa, luminożità viżiva, difett fil-kamp viżiv, tara frak fl-ilma tal-għajnejn, u xantopsija) b'voriconazole kienu komuni ħafna.
English: Monitoring for voriconazoleassociated adverse reactions is recommended if voriconazole is used sequentially after fluconazole (see section 4.5).
Hungarian: Monitoraġġ ta' reazzjonijiet avversi assoċjati ma' voriconazole huwa rrakkomandat jekk voriconazole se jintuża wara fluconazole (ara sezzjoni 4.5).
English: However, as there were only 9 cases available for EUCAST analysis, there is currently insufficient evidence to set clinical breakpoints for C. krusei.
Hungarian: Madankollu, peress li kien hemm biss 9 każ disponibbli għall-analiżi minn EUCAST, bħalissa m'hemmx evidenza biżżejjed biex jiġu stabbiliti breakpoints kliniċi għal C. krusei.
English: Psychiatric disorders depression, hallucination, anxiety, insomnia, agitation, confusional state
Hungarian: Disturbi psikjatriċi depressjoni, alluċinazzjoni, ansjetà, nuqqas ta' rqad, aġitazzjoni, stat konfużjonali
English: Voriconazole has been shown to be more selective for fungal cytochrome P-450 enzymes than for various mammalian cytochrome P-450 enzyme systems.
Hungarian: Kien muri li voriconazole huwa aktar selettiv għall-enzimi taċċitokromu fungali P450 milli għas-sistemi diversi taċ-ċitokromu fungali P450 tal-mammiferi.
English: 3b Screw the syringe onto the vial adapter.
Hungarian: 3b Waħħal is-siringa ma' l-adatattur tal-kunjett.
English: Efavirenz 300 mg QD, coadministered with voriconazole 400 mg BID
Hungarian: Efavirenz 300 mg QD, amministrazzjoni flimkien ma' voriconazole 400 mg BID
English: Paediatric population
Hungarian: Popolazzjoni pedjatrika
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Hungarian: Ir-rekwiżiti tar- rapporti perjodiċi aġġornati dwar is-sigurtà għal dan il-prodott mediċinali huma mniżżla fil-lista tad-dati ta' referenza tal-Unjoni (lista EURD) prevista skont l-Artikolu 107c(7) tad-Direttiva 2001/83/KE u kwalunkwe aġġornament sussegwenti ppubblikati fuq il-portal elettroniku Ewropew tal-mediċini.
English: Duration of prophylaxis
Hungarian: Tul ta' żmien tal-profilassi
English: The ERG measures electrical currents in the retina.
Hungarian: L-ERG ikejjel il-kurrenti elettriċi fir-retina.
English: Blister foil for 200 mg film-coated tablets (all blister packs)
Hungarian: Fojl tal-folji għal 200 mg pilloli miksijin b'rita (il-pakketti tal-folji kollha)
English: No subject experienced an interval exceeding the potentially clinically-relevant threshold of 500 msec.
Hungarian: L-ebda suġġett ma esperjenza intervall li qabeż il-limitu potenzjalment klinikament rilevanti ta' 500 msec.
English: It may only be continued up to 180 days after transplantation in case of continuing immunosuppression or graft versus host disease (GvHD) (see section 5.1).
Hungarian: Tista' titkompla biss għal sa 180 jum wara t-trapjant f'każ tattkomplija tal-immunosoppressjoni jew tal-graft versus host disease (GvHD) (ara sezzjoni 5.1).
English: Пфайзер Люксембург САРЛ, Клон България Тел.
Hungarian: Pfizer Luxembourg SARL Filialas Lietuvoje Tel.
English: Renal impairment
Hungarian: Mhux irrakkomandat
English: Patients have developed severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) (uncommon), toxic epidermal necrolysis (TEN) (rare), drug reaction with eosinophilia and systemic symptoms (DRESS) (rare) and erythema multiforme (rare) during treatment with VFEND (see section 4.4).
Hungarian: reazzjonijiet avversi kutanji severi (SCARs, severe cutaneous adverse reactions), inkluż is-sindromu ta' Stevens-Johnson (SJS) (mhux komuni), nekroliżi epidermika tossika (TEN, toxic epidermal necrolysis) (rari), reazzjoni għall-mediċina b'sintomi ta' esinofilja u sistemiċi (DRESS) (rari) u eritema multiformi (rari) waqt kura b'VFEND (ara sezzjoni 4.4).
English: Each bag contains 50 ml of sodium chloride 0.9% in Water for Injections.
Hungarian: Kull borża fiha 50 ml ta' sodium chloride 0.9% fl-Ilma tal-Injezzjonijiet.
English: Tabulated list of adverse reactions
Hungarian: Lista f'tabella tar-reazzjonijiet avversi
English: Clinical studies examining QTc interval
Hungarian: Studji kliniċi li eżaminaw l-Intervall QTc
English: VFEND 50 mg film-coated tablets White to off-white, round tablet, debossed “Pfizer” on one side and “VOR50”on the reverse.
Hungarian: Pillola ta' kulur abjad għal offwajt, tonda, bi “Pfizer” imnaqqax fuq naħa u “VOR50” fuq in-naħa loħra.
English: EU/1/02/212/001 2 film-coated tablets EU/1/02/212/002 10 film-coated tablets EU/1/02/212/003 14 film-coated tablets EU/1/02/212/004 20 film-coated tablets EU/1/02/212/005 28 film-coated tablets EU/1/02/212/006 30 film-coated tablets EU/1/02/212/007 50 film-coated tablets EU/1/02/212/008 56 film-coated tablets EU/1/02/212/009 100 film-coated tablets EU/1/02/212/028 2 film-coated tablets EU/1/02/212/029 10 film-coated tablets EU/1/02/212/030 14 film-coated tablets EU/1/02/212/031 20 film-coated tablets EU/1/02/212/032 28 film-coated tablets EU/1/02/212/033 30 film-coated tablets EU/1/02/212/034 50 film-coated tablets EU/1/02/212/035 56 film-coated tablets EU/1/02/212/036 100 film-coated tablets
Hungarian: EU/1/02/212/001 2 pilloli miksijin b'rita EU/1/02/212/002 10 pilloli miksija b'rita EU/1/02/212/003 14-il pillola miksija b'rita EU/1/02/212/004 20 pillola miksija b'rita EU/1/02/212/005 28 pillola miksija b'rita EU/1/02/212/006 30 pillola miksija b'rita EU/1/02/212/007 50 pillola miksija b'rita EU/1/02/212/008 56 pillola miksija b'rita EU/1/02/212/009 100 pillola miksija b'rita
English: 8 mg/kg dose (number of vials)
Hungarian: doża ta' 8 mg/kg (numru ta' kunjetti)
English: The most commonly reported adverse reactions were visual impairment, pyrexia, rash, vomiting, nausea, diarrhoea, headache, peripheral oedema, liver function test abnormal, respiratory distress and abdominal pain.
Hungarian: L-aktar reazzjonijiet avversi rrapportati b'mod komuni kienu indeboliment fil-vista, deni, raxx, rimettar, dardir, dijarea, uġigħ ta' ras, edema periferali, riżultat anormali tat-test tal-funzjoni tal-fwied, problemi respiratorji u uġigħ ta' żaqq.
English: This metabolite has minimal antifungal activity and does not contribute to the overall efficacy of voriconazole.
Hungarian: Dan il-metabolit għandu attività antifungali limitata u ma jikkontribwixxix għall-effikaċja globali ta' voriconazole.
English: Increased tacrolimus levels have been associated with nephrotoxicity.
Hungarian: Livelli akbar ta' tacrolimus ġew assoċjati ma' nefrotossiċità.
English: • Efavirenz (used for treating HIV) in doses of 400 mg and above once daily
Hungarian: • Efavirenz (użat għall-kura tal-HIV) f'dożi ta' 400 mg u aktar darba kuljum
English: An 8 mg/kg intravenous dose will provide voriconazole exposure approximately 2-fold higher than a 9 mg/kg oral dose.
Hungarian: Doża fil-vina ta' 8 mg/kg ser tagħti esponiment ta' voriconazole ta' bejn wieħed u ieħor darbtejn aktar mid-doża orali ta' 9 mg/kg.
English: VFEND is also available as 50 mg and 200 mg film-coated tablets, 200 mg powder for solution for injection and 200 mg powder and solvent for solution for infusion.
Hungarian: VFEND huwa disponibbli wkoll bħala pilloli ta' 50 mg u ta' 200 mg miksijin b'rita, 200 mg trab għal għall-injezzjoni u trab u solvent ta' 200 mg għal soluzzjoni għall-infużjoni.
English: Secondary Prophylaxis of IFI - Efficacy in HSCT recipients with prior proven or probable IFI Voriconazole was investigated as secondary prophylaxis in an open-label, non-comparative, multicenter study of adult allogeneic HSCT recipients with prior proven or probable IFI.
Hungarian: Voriconazole ġie investigat bħala profilassi sekondarja fi studju open-label, mhux komparattiv, multiċentriku, ta' riċevituri adulti alloġeniċi ta' HSCT mingħajr IFIs li ġew ikkonfermati jew li setgħu seħħew fil-passat.
English: HDPE tablet containers containing 2, 30 or 100 film-coated tablets.
Hungarian: Kontenituri tal-HDPE għall-pilloli li fihom 2, 30 jew 100 pillola miksija b'rita.
English: It is therefore recommended to use the oral suspension formulation in children aged 2 to <12.
Hungarian: Għalhekk huwa rrakkomandat li tintuża l-formulazzjoni tas-suspensjoni orali fi tfal ta' 2 sa <12-il sena.
English: The maintenance dose of voriconazole may be increased to 5 mg/kg intravenously BID or from 200 mg to 350 mg orally BID (100 mg to 200 mg orally BID in patients less than 40 kg) (see section 4.2).
Hungarian: Id-doża ta' manteniment ta' voriconazole tista' tiżdied għal 5 mg/kg fil-vina BID jew minn 200 mg sa 350 mg b'mod orali BID, (100 mg sa 200 mg b'mod orali BID f'pazjenti li jiżnu anqas minn 40 kg) (ara sezzjoni 4.2).
English: In clinical trials, there have been cases of serious hepatic reactions during treatment with voriconazole (including clinical hepatitis, cholestasis and fulminant hepatic failure, including fatalities).
Hungarian: Fi studji kliniċi, kien hemm każijiet ta' reazzjonijiet epatiċi waqt kura b'voriconazole (inkluż epatite klinika, kolestażi u insuffiċjenza tal-fwied f'daqqa, inkluż imwiet).
English: Increased ciclosporin levels have been associated with nephrotoxicity.
Hungarian: Livelli akbar ta' ciclosporin ġew assoċjati ma' nefrotossiċità.
English: This enzyme exhibits genetic polymorphism.
Hungarian: Dan l-enzim jippreżenta polimorfiżmu ġenetiku.
English: Coadministration of voriconazole and sirolimus is contraindicated (see section
Hungarian: Amministrazzjoni ta' voriconazole flimkien ma' sirolimus huwa kontraindikat (ara sezzjoni 4.3).
English: • Indinavir and other HIV protease inhibitors (used for treating HIV)
Hungarian: • Indinavir u inibituri oħra tal-protease ta' l-HIV (użati għall-kura ta' l-HIV)
English: • Not for administration as a bolus injection.
Hungarian: • M'għandux jingħata bħala injezzjoni bolus.
English: Do not take VFEND: - If you are allergic to the active ingredient voriconazole, or to sulfobutylether beta cyclodextrin sodium
Hungarian: Tiħux b'VFEND: - Jekk inti allerġiku għal sustanza attiva voriconazole, jew għal sulfobutylether beta cyclodextrin sodium (elenkati f'sezzjoni 6).
English: AUC, AUCt and AUC0- represent area under the curve over a dosing interval, from time zero to the time with detectable measurement and from time zero to infinity, respectively.
Hungarian: L-AUC, AUCt u AUC0- jirrapreżentaw l-arja ta' taħt il-kurva għal interval ta' dożaġġ, minn ħin zero sal-aħħar kejl kwantifikabbli u minn ħin zero sal-infinità, rispettivament.
English: Following constitution, the volume of the suspension is 75 ml, providing a usable volume of 70 ml.
Hungarian: Wara li tiġi kostitwita, il-volum tas-suspensjoni jkun 75 ml, li jipprovdi volum użabbli ta' 70 ml.
English: After administration of a radiolabelled dose of voriconazole, approximately 80% of the radioactivity is recovered in the urine after multiple intravenous dosing and 83% in the urine after multiple oral dosing.
Hungarian: Wara l-amministrazzjoni ta' doża radjutikkettata ta' voriconazole, madwar 80% tar-radjuattività tiġi rkuprata fl-awrina wara dożar multiplu fil-vini u 83% fl-awrina wara dożar multiplu orali.
English: IFI to day 100
Hungarian: Suċċess f'jum 100
English: VFEND is also available as 200 mg powder for solution for infusion, 200 mg powder and solvent for solution for infusion and 40 mg/ml powder for oral suspension.
Hungarian: VFEND huwa disponibbli wkoll bħala trab ta' 200 mg għal soluzzjoni għall-infużjoni, trab u solvent ta' 200 mg għal soluzzjoni għall-infużjoni u trab ta' 40 mg/ml għal suspensjoni orali.
English: • Oxycodone and other long-acting opiates such as hydrocodone (used for moderate to severe pain)
Hungarian: • Oxycodone u opiates oħra li jaħdmu fuq tul ta' żmien bħal hydrocodone (użati kontra l-uġigħ moderat u sever)
English: Blister foil for 50 mg film-coated tablets (all blister packs)
Hungarian: Fojl tal-folji għal 50 mg pilloli miksijin b'rita (il-pakketti tal-folji kollha)
English: Patients being treated with voriconazole are likely to be treated concomitantly with nephrotoxic medicinal products and have concurrent conditions that may result in decreased renal function (see section 4.8).
Hungarian: Il-pazjenti li jkunu qed jiġu kkurati b'voriconazole huma probabbli li jiġu kkurati fl-istess waqt bi prodotti mediċinali nefrotossiċi u jkollhom kondizzjonijiet konkorrenti li jistgħu jwasslu għal funzjoni mnaqqsa tal-kliewi (ara sezzjoni 4.8).
English: 1 single use 30 ml clear Type I glass vial with rubber stopper and aluminium cap with plastic seal of VFEND 200 mg, powder for solution.
Hungarian: 1 kunjett tal-ħġieġ ċar ta' 30 ml, ta' Tip I, li jintuża darba biss, b'tapp tal-lastku u għatu tal-aluminju b'siġill tal-plastik ta' VFEND 200 mg, trab għal soluzzjoni.
English: VFEND 50 mg film-coated tablets VFEND 200 mg film-coated tablets Voriconazole
Hungarian: VFEND 50 mg pilloli miksijin b'rita VFEND 200 mg pilloli miksijin b'rita Voriconazole
English: Pharmacokinetics in special patient groups
Hungarian: Farmakokinetika fi gruppi ta' pazjenti speċjali
English: 8 mg/kg twice daily
Hungarian: 8 mg/kg darbtejn kuljum
English: • Health Care Professional (HCP) Checklist for Phototoxicity, SCC and Hepatic toxicity: - Reminds HCPs of the risks of phototoxicity, skin SCC and hepatotoxicity reported with voriconazole use.
Hungarian: • Checklist tal-Professjonist fil-Qasam Mediku (HCP) għal Fototossiċità, SCC u Tossiċità talFwied
English: The predicted total exposures in children following IV maintenance doses of 4 and 8 mg/kg twice daily were comparable to those in adults following 3 and 4 mg/kg IV twice daily, respectively.
Hungarian: Lesponimenti totali mbassra fit-tfal wara dożi ta' manteniment fil-vina ta' 4 u 8 mg/kg darbtejn kuljum kienu kumparabbli ma' dawk tal-adulti wara dożi fil-vina ta' 3 u 4 mg/kg darbtejn kuljum, rispettivament.
English: VFEND must not be diluted with 4.2% Sodium Bicarbonate Infusion.
Hungarian: VFEND m'għandux jiġi dilwit b'4.2% Infużjoni ta' Bikarbonat tas-Sodju.
English: The recommended doses in children and adolescent patients are based on a population pharmacokinetic analysis of data obtained from 112 immunocompromised paediatric patients aged 2 to <12 years and 26 immunocompromised adolescent patients aged 12 to <17 years.
Hungarian: Id-dożi rrakkomandati fil-pazjenti tfal u adoloxxenti huma bbażati fuq analiżi farmakokinetika talpopolazzjoni ta' dejta miksuba minn 112 pazjenti immunokompromessi tfal fl-etajiet ta' 2 sa <12-il sena u 26 pazjenti adoloxxenti immunokompromessi fl-etajiet ta' 12 sa <17-il sena.
English: Depending on the severity of symptoms, consideration should be given to stopping treatment (see section 4.8).
Hungarian: Jiddependi fuq is-severità tas-sintomi, għandha tingħata kunsiderazzjoni għat-twaqqif tat-trattament (ara sezzjoni 4.8).
English: Vial contains 200 mg of voriconazole.
Hungarian: Kunjett fih 200 mg ta' voriconazole.
English: A relationship between plasma concentrations and age was observed.
Hungarian: Kienet osservata relazzjoni bejn il-konċentrazzjonijiet fil-plasma u l-età.
English: 300 mg QD (coadministered with voriconazole 400 mg BID)
Hungarian: 300 mg QD (amministrat flimkien ma' voriconazole 400 mg BID)
English: 4 mg/kg twice daily 200 mg twice daily 100 mg twice daily
Hungarian: 4 mg/kg darbtejn kuljum200 mg darbtejn kuljum 100 mg darbtejn kuljum
English: BATCH NUMBER
Hungarian: NUMRU TAL-LOTT
English: In vitro studies show that voriconazole may inhibit the metabolism of HIV protease inhibitors and the metabolism of voriconazole may also be inhibited by HIV protease inhibitors.
Hungarian: Studji in vitro wrew li voriconazole jista' jwaqqaf il-metaboliżmu tal-inibituri tal-protease tal-HIV u lmetaboliżmu ta' voriconazole jista' wkoll jiġi mwaqqaf mill-inibituri tal-protease tal-HIV.